Invention Grant
- Patent Title: Expression from transposon-based vectors and uses
-
Application No.: US17190954Application Date: 2021-03-03
-
Publication No.: US11692193B2Publication Date: 2023-07-04
- Inventor: Jeffrey T. McGrew , Pauline S. Smidt , E-Ching Ong
- Applicant: Just-Evotec Biologics, Inc.
- Applicant Address: US WA Seattle
- Assignee: Just-Evotec Biologies, Inc.
- Current Assignee: Just-Evotec Biologies, Inc.
- Current Assignee Address: US WA Seattle
- Agency: Law Offices of Nisan Steinberg
- The original application number of the division: US16286551 2019.02.26
- Main IPC: C12N15/00
- IPC: C12N15/00 ; C12N15/52 ; C12N15/65 ; C12N15/113 ; C12N15/85 ; C12N15/67

Abstract:
Recombinant expression vectors are disclosed that include a control sequence for recombinant expression of proteins of interest; the control sequence combines a mCMV enhancer sequence with a rat EF-1alpha intron sequence. Some of the vectors are useful for tetracycline-inducible expression. Some of the vectors contain a 5′ PiggyBac ITR and a 3′ PiggyBac ITR to promote genomic integration into a host cell chromosome. A method of selecting a stable production cell line for manufacturing a protein of interest is also disclosed. Also disclosed are mammalian host cells comprising the inventive recombinant expression vectors and a method of producing a protein of interest, in vitro, involving the mammalian host cell.
Public/Granted literature
- US20210189403A1 EXPRESSION FROM TRANSPOSON-BASED VECTORS AND USES Public/Granted day:2021-06-24
Information query
IPC分类: